Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.55 |
| ▸ | CES1 | P23141 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.52 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.51 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.51 |
| ▸ | PLK1 | P53350 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6831412 | 0.91 | CES2 (0.50) | CES2CES1CA1CA2HPGD | |
| SCHEMBL13412202 | 0.83 | CES2 (0.53) | CES2CES1CA1CA2HPGD | |
| SCHEMBL5434766 | 0.81 | CA1 (0.53) | CA1CA2HPGDNPSR1MCOLN3 | |
| SCHEMBL7270764 | 0.80 | STS (0.59) | CES2CES1HPGDPARP1NPSR1 | |
| SCHEMBL30527863 | 0.79 | CES2 (0.64) | CES2CES1CA1CA2HPGD | |
| SCHEMBL12989210 | 0.79 | CES2 (0.61) | CES2CES1PARP1MEN1MAPK1 | |
| SCHEMBL3874936 | 0.79 | NPSR1 (0.48) | HPGDNPSR1MCOLN3LMNAMEN1 | |
| SCHEMBL6834847 | 0.78 | CES2 (0.52) | CES2CES1CA1CA2HPGD | |
| SCHEMBL1659309 | 0.78 | HPGD (0.73) | CES2CES1CA1CA2HPGD | |
| SCHEMBL2921303 | 0.78 | HPGD (0.56) | CES2CA1CA2HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858635-B2 | Spiro compounds as modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-12-28 | — | — | US | disclosed |
| US-7741365-B2 | Peripheral cannabinoid receptor (CB2) selective ligands | UNIVERSITY OF CONNECTICUT (US) | 2010-06-22 | — | — | US | disclosed |
| US-20080015179-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2008-01-17 | — | — | US | disclosed |
| EP-1223808-B1 | PERIPHERAL CANNABINOID RECEPTOR (CB2) SELECTIVE LIGANDS | UNIV CONNECTICUT (US) | 2007-03-07 | — | — | EP | disclosed |
| US-20060189610-A1 | Peripheral cannabinoid receptor (CB2) selective ligands | UNIVERSITY OF CONNECTICUT | 2006-08-24 | — | — | US | disclosed |
| US-6995187-B1 | Peripheral cannabinoid receptor (CB2) selective ligands | UNIVERSITY OF CONNECTICUT (US) | 2006-02-07 | — | — | US | disclosed |
| EP-1223808-A4 | PERIPHERAL CANNABINOID RECEPTOR (CB2) SELECTIVE LIGANDS | UNIV CONNECTICUT (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-1223808-A1 | PERIPHERAL CANNABINOID RECEPTOR (CB2) SELECTIVE LIGANDS | THE UNIVERSITY OF CONNECTICUT (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001028329-A1 | PERIPHERAL CANNABINOID RECEPTOR (CB2) SELECTIVE LIGANDS | UNIVERSITY OF CONNECTICUT (US) | 2001-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189610-A1 | Peripheral cannabinoid receptor (CB2) selective ligands | CNR2, CNR1, GPR18 | CES2 1077/4885CES1 1929/4885CA1 2587/4885 |
| US-20080015179-A1 | Modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | CES2 978/4885CES1 917/4885CA1 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.